Clinical trials of once-weekly 2.4 mg semaglutide have shown significant, sustained weight loss when combined with lifestyle intervention
D., Muzio, F
20 GojkovicS.KrezicI.VranesH.ZizekH.DrmicD.Horvat PavlovK.et al (2021a)
A: Federally, yes DEA waivers through at least Dec 31, 2025 allow controlled substance prescribing via telehealth without prior in-person exam
Weight fluctuations on levothyroxine are typically due to under-treatment or over-treatment rather than the medication itself. Indeed, its not the levothyroxine that can cause weight gainits the condition for which people are taking it, which is hypothyroidism, or underactive thyroid
Behavioral and dietary interventions for weight loss are known to improve psychological well-being, including self-esteem, body image, health-related quality of life, and mental health, suggesting weight loss with GLP-1s may have similar beneficial impacts